⚠ Research Use Only. For laboratory and scientific research purposes only. Not intended for human consumption, veterinary use, or any other purpose.
Retatrutide vs Tirzepatide: A Comparative Research Overview
Research Compounds
View full compound profiles, COAs, and documentation on the product pages.
Related Research
Retatrutide is a once-weekly injectable triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, under investigation for metabolic research applications.
Tirzepatide is a synthetic dual agonist peptide targeting GIP and GLP-1 receptors, with a once-weekly dosing interval enabled by a fatty acid conjugation strategy.
Research use only. All content on this page is for laboratory and scientific research purposes only. Not for human or veterinary use. Not for diagnostic or therapeutic purposes. Apex Molecular Labs makes no representations regarding safety, efficacy, or suitability for any use beyond in vitro research.